Douglas Love
2021
In 2021, Douglas Love earned a total compensation of $8.1M as President and Chief Executive Officer at Annexon, a 75% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $297,110 |
|---|---|
| Option Awards | $7,231,250 |
| Salary | $533,883 |
| Total | $8,062,243 |
Love received $7.2M in option awards, accounting for 90% of the total pay in 2021.
Love also received $297.1K in non-equity incentive plan and $533.9K in salary.
Rankings
In 2021, Douglas Love's compensation ranked 1,437th out of 12,415 executives tracked by ExecPay. In other words, Love earned more than 88.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,437 out of 12,415 | 88th |
Division Manufacturing | 518 out of 5,508 | 91st |
Major group Chemicals And Allied Products | 192 out of 2,378 | 92nd |
Industry group Drugs | 159 out of 2,099 | 92nd |
Industry Pharmaceutical Preparations | 108 out of 1,549 | 93rd |
Source: SEC filing on April 27, 2022.
Love's colleagues
We found five more compensation records of executives who worked with Douglas Love at Annexon in 2021.
2021
Larry Mattheakis
Annexon
Chief Scientific Officer
2021
Ted Yednock
Annexon
EVP and Chief Innovation Officer
2021
Sanjay Keswani
Annexon
Chief Medical Officer
2021
Jennifer Lew
Annexon
Chief Financial Officer
2021
Michael Overdorf
Annexon